A detailed history of First Trust Advisors LP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 52,067 shares of SUPN stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,067
Previous 21,493 142.25%
Holding current value
$1.97 Million
Previous $574,000 182.75%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$25.77 - $35.16 $787,891 - $1.07 Million
30,574 Added 142.25%
52,067 $1.62 Million
Q2 2024

Aug 13, 2024

SELL
$25.99 - $33.85 $761,429 - $991,703
-29,297 Reduced 57.68%
21,493 $574,000
Q1 2024

May 13, 2024

SELL
$27.11 - $35.17 $116,085 - $150,597
-4,282 Reduced 7.78%
50,790 $1.73 Million
Q4 2023

Feb 13, 2024

BUY
$22.72 - $29.68 $86,994 - $113,644
3,829 Added 7.47%
55,072 $1.59 Million
Q3 2023

Nov 13, 2023

BUY
$27.57 - $32.91 $451,376 - $538,802
16,372 Added 46.95%
51,243 $1.41 Million
Q2 2023

Aug 14, 2023

BUY
$29.91 - $38.73 $578,160 - $748,650
19,330 Added 124.38%
34,871 $1.05 Million
Q1 2023

May 15, 2023

BUY
$34.93 - $42.03 $26,931 - $32,405
771 Added 5.22%
15,541 $563,000
Q4 2022

Feb 09, 2023

SELL
$31.09 - $37.88 $1.42 Million - $1.74 Million
-45,821 Reduced 75.62%
14,770 $526,000
Q3 2022

Nov 14, 2022

SELL
$28.79 - $35.41 $161,828 - $199,039
-5,621 Reduced 8.49%
60,591 $2.05 Million
Q2 2022

Aug 12, 2022

BUY
$25.33 - $34.25 $1.68 Million - $2.27 Million
66,212 New
66,212 $1.92 Million
Q4 2021

Feb 08, 2022

SELL
$26.37 - $34.22 $2.91 Million - $3.77 Million
-110,227 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$23.54 - $31.39 $2.15 Million - $2.86 Million
-91,261 Reduced 45.29%
110,227 $2.94 Million
Q2 2021

Aug 16, 2021

BUY
$26.72 - $33.19 $3.16 Million - $3.93 Million
118,394 Added 142.48%
201,488 $6.2 Million
Q1 2021

May 14, 2021

BUY
$24.15 - $31.45 $110,462 - $143,852
4,574 Added 5.83%
83,094 $2.18 Million
Q4 2020

Feb 02, 2021

BUY
$17.7 - $25.81 $283,766 - $413,785
16,032 Added 25.66%
78,520 $1.98 Million
Q3 2020

Nov 05, 2020

BUY
$20.2 - $25.05 $62,478 - $77,479
3,093 Added 5.21%
62,488 $1.3 Million
Q2 2020

Jul 22, 2020

BUY
$17.09 - $24.89 $1.02 Million - $1.48 Million
59,395 New
59,395 $1.41 Million
Q1 2020

May 06, 2020

SELL
$14.45 - $24.69 $272,642 - $465,850
-18,868 Closed
0 $0
Q4 2019

Feb 03, 2020

BUY
$19.93 - $29.13 $76,551 - $111,888
3,841 Added 25.56%
18,868 $448,000
Q3 2019

Nov 04, 2019

SELL
$25.47 - $33.37 $13,550 - $17,752
-532 Reduced 3.42%
15,027 $413,000
Q2 2019

Jul 30, 2019

BUY
$29.96 - $38.87 $60,998 - $79,139
2,036 Added 15.06%
15,559 $515,000
Q1 2019

May 09, 2019

SELL
$32.77 - $41.99 $610,111 - $781,769
-18,618 Reduced 57.93%
13,523 $474,000
Q4 2018

Feb 07, 2019

SELL
$30.84 - $49.51 $1.88 Million - $3.02 Million
-60,999 Reduced 65.49%
32,141 $1.07 Million
Q3 2018

Oct 25, 2018

BUY
$42.7 - $56.55 $691,825 - $916,223
16,202 Added 21.06%
93,140 $4.69 Million
Q2 2018

Aug 02, 2018

BUY
$44.1 - $59.85 $1.84 Million - $2.49 Million
41,658 Added 118.08%
76,938 $4.61 Million
Q1 2018

Apr 23, 2018

SELL
$37.15 - $46.9 $270,414 - $341,385
-7,279 Reduced 17.1%
35,280 $1.62 Million
Q4 2017

Feb 08, 2018

SELL
$36.4 - $42.6 $502,938 - $588,604
-13,817 Reduced 24.51%
42,559 $1.7 Million
Q3 2017

Oct 24, 2017

BUY
$36.75 - $49.65 $2.07 Million - $2.8 Million
56,376
56,376 $2.26 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.03B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.